Kyntra Bio Inc (KYNB) vs NewcelX Ltd. (NCEL)

Kyntra Bio Inc and NewcelX Ltd. are both Biotechnology companies. Kyntra Bio Inc and NewcelX Ltd. are of similar size ($14.5M and $14.5M). NewcelX Ltd. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Kyntra Bio Inc leads on 7 and NewcelX Ltd. on 4.

Valuation

Metric KYNB NCEL Biotechnology median
P/E 0.08 n/m 11.36
P/S 3.10 n/m 9.12
P/B n/m 4.76 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales 15.20 n/m 8.56
Earnings yield 1,279.66% (59.30%) (34.18%)
Free cash flow yield (265.81%) (17.06%) (23.62%)

Profitability

Metric KYNB NCEL Biotechnology median
Gross margin 6.28% 0.00% 67.24%
Operating margin (1,089.78%) — 0.00%
Net margin 3,967.77% 0.00% 0.00%
Free cash flow margin (824.19%) 0.00% 0.00%
Return on equity (157.83%) 0.00% (50.28%)
Return on assets 131.26% 0.00% (45.89%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KYNB NCEL Biotechnology median
Revenue growth (TTM) (37.15%) — 6.96%
EPS growth (last fiscal year) 478.08% 11.18% 29.86%
Revenue growth, 5-year CAGR (48.42%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KYNB NCEL Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 2.69 0.40 4.72
Net debt to EBITDA 1.97 0.74 1.01

Dividend

Metric KYNB NCEL Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric KYNB NCEL Biotechnology median
Market cap 14.54m 14.48m 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack